Delivery Order SPE2DB20D1102-SPE2DB25FC6KU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,690.14 to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Isotretinoin is a potent oral retinoid medication primarily used for severe acne treatment, and this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Isotretinoin 30 mg capsules (30-count unit) with a ceiling value of $5,913.36. This is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and was competitively awarded without a set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Isotretinoin is a potent...
- The Defense Logistics Agency awarded a delivery order valued at $2,383.74 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) on September 25, 2025, with completion scheduled for September 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Isotretinoin is a potent oral retinoid primarily used for the treatment of severe acne and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) valued at $18,281.62 under a firm fixed-price contract with no set-aside designation. The contract was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Isotretinoin is a prescription medication primarily used for treating...
- The Defense Logistics Agency awarded a delivery order valued at $20,726.74 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) under a firm fixed-price contract. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and is not designated as a set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. Isotretinoin...
- The Defense Logistics Agency awarded a delivery order valued at $35,121.23 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,093.00 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 40 mg capsules (30-count) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Isotretinoin 20mg in a 30-count package. This is a firm fixed-price delivery order with a ceiling value of $2,283.67 and an ultimate completion date of April 24, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 40 mg capsules (30-count packages) valued at $2,332.80, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,522.91 delivery order to AmerisourceBergen Drug Corp for 30 capsules of Isotretinoin 30 mg on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical procurement, serving...
- SPE2DB20D1102Indefinite Delivery Contract
- SPE2DB20D1102-SPE2DB25FC6KUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,173.84 to AmerisourceBergen Drug Corp for Isotretinoin 20 mg capsules (30-count units) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Isotretinoin is a potent retinoid medication primarily used for severe acne treatment, representing a specialized pharmaceutical requirement within the federal medical supply chain. This delivery order operates as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999.9 million through December 2026. As a major pharmaceutical distributor serving federal healthcare needs, AmerisourceBergen leverages this comprehensive IDC vehicle to supply medications, vaccines, and medical supplies to military and veteran healthcare systems globally. The company's extensive portfolio of federal medical procurements demonstrates its established capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains for the Department of Defense and other federal healthcare agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/18/25 |